Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
AssigneeNitto Denko Corporation
InventorsTakuya SHISHIDO, Daisuke ASARI, Mitsuhiko HORI
Life of this patent
Estimating the term…
Abstract
The present invention aims to provide a vaccine pharmaceutical composition universally usable for induction of cellular immunity against various antigens and exerting a high cellular immunity inducing effect. The present invention relates to a vaccine pharmaceutical composition for inducing cellular immunity, containing: an antigen; and a first cellular immunity induction promoter that is a bisphosphonate.
Claims18
A vaccine pharmaceutical composition for inducing cellular immunity, comprising:
- an antigen;
- and
- a first cellular immunity induction promoter that is a bisphosphonate.
A method for inducing cellular immunity comprising administering a vaccine pharmaceutical composition, comprising:
- an antigen;
- and
- a first cellular immunity induction promoter that is a bisphosphonate,
- wherein the administration induces a cellular immune response.
Dependencies are inferred from the claim text.